newsfilter
← Latest News
Business Wire·

MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®

MacroGenics, Inc. (NASDAQ:MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, and TerSera